Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene D Kwon

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Clinical Genitourinary Cancer|January 24, 2007
Significance of B7-H1 overexpression in kidney cancerR Houston Thompson, Eugene D Kwon
Expert Review of Anticancer Therapy|January 25, 2023
Addressing the need for more therapeutic options in neuroendocrine prostate cancerJayson Kemble, Eugene D Kwon, R Jeffrey Karnes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapyR Houston Thompson, Haidong Dong, Eugene D Kwon
The Journal of Urology|January 10, 2004
Immunotherapy for urological malignanciesKent G Krejci, Mary A Markiewicz, Eugene D Kwon
Urologic Oncology|September 12, 2006
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancerR Houston Thompson, James P Allison, Eugene D Kwon
Current Pharmaceutical Design|March 7, 2006
Immunotherapy for prostate cancerR Jeffrey Karnes, Christopher M Whelan, Eugene D Kwon
Immunotherapy|May 7, 2010
Inhibitors of B7-CD28 costimulation in urologic malignanciesR Houston Thompson, Eugene D Kwon, James P Allison
Current Cancer Drug Targets|February 20, 2007
Costimulation, coinhibition and cancerBrant A Inman, Xavier Frigola, Haidong Dong, et al.
Current Urology Reports|April 21, 2015
Immunotherapy in prostate cancerIlya Sobol, R H Thompson, Haidong Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Prostate cancer immunology: biology, therapeutics, and challengesW Scott Webster, Eric J Small, Brian I Rini, et al.
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Clinical Genitourinary Cancer|January 24, 2007
Significance of B7-H1 overexpression in kidney cancerR Houston Thompson, Eugene D Kwon
Expert Review of Anticancer Therapy|January 25, 2023
Addressing the need for more therapeutic options in neuroendocrine prostate cancerJayson Kemble, Eugene D Kwon, R Jeffrey Karnes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapyR Houston Thompson, Haidong Dong, Eugene D Kwon
The Journal of Urology|January 10, 2004
Immunotherapy for urological malignanciesKent G Krejci, Mary A Markiewicz, Eugene D Kwon
Urologic Oncology|September 12, 2006
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancerR Houston Thompson, James P Allison, Eugene D Kwon
Current Pharmaceutical Design|March 7, 2006
Immunotherapy for prostate cancerR Jeffrey Karnes, Christopher M Whelan, Eugene D Kwon
Immunotherapy|May 7, 2010
Inhibitors of B7-CD28 costimulation in urologic malignanciesR Houston Thompson, Eugene D Kwon, James P Allison
Current Cancer Drug Targets|February 20, 2007
Costimulation, coinhibition and cancerBrant A Inman, Xavier Frigola, Haidong Dong, et al.
Current Urology Reports|April 21, 2015
Immunotherapy in prostate cancerIlya Sobol, R H Thompson, Haidong Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Prostate cancer immunology: biology, therapeutics, and challengesW Scott Webster, Eric J Small, Brian I Rini, et al.
Pageof 15